New joint imaging tools in osteoarthritis. I--Validation and preliminary experience with GGGS treatment
Serni, U.; Marin, G.; Matucci, A.; Dal Pozzo, G.C.; Petacchi, D.; Naldoni, G.C.; Taverni, N.
International Journal of Clinical Pharmacology Research 13 Suppl: 43-47
1993
ISSN/ISBN: 0251-1649 PMID: 7995681 Document Number: 415563
In the pathology of joints, the main aim is an early diagnosis. In osteoarthritis (OA), where laboratory support is particularly poor, traditional radiology is informative only when the pathologic process is so advanced that prevention is difficult, either by changing life habits or by treating with chondroprotective drugs. Therefore an ideal diagnostic imaging tool should be sensitive, specific, reproducible and not invasive. In our opinion, Nuclear Magnetic Resonance (NMR) has all these characteristics and in particular can show meaningful pictures of cartilage and subchondral bone. We therefore compared NMR and traditional radiology to the gross pathology shown by arthroscopy at an early stage of OA, before and after treatment with glycosamino-glucuron-glycan-sulphate (GGGS) or placebo. Our results suggest that NMR is quite meaningful and can detect early OA joint modifications. With this technique the placebo-treated OA patients showed a natural increase in their pathologic picture, while the GGGS-treated patients seemed to experience a retardation in the progression of the disease.